Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 4.67B |
| Enterprise Value | 3.31B |
| P/E Ratio | 24.94 |
| PEG Ratio | -0.38 |
| Price/Sales Ratio | 3.35 |
| Price/Book Ratio | 0.96 |
| Enterprise/Revenue | 2.48 |
| Enterprise/EBITDA | 16.41 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.12 |
| Operating Margin | 0.11 |
| Return On Assets | 0.03 |
| Return On Equity | 0.03 |
| Revenue | 1.39B |
| Revenue/Share | 4.34 |
| Gross Profit | 1.39B |
| EBITDA | 533.4M |
| Net Income | 418.37M |
| Diluted EPS | 1.62 |
| Total Cash | 2.35B |
| Total Cash/Share | 7.83 |
| Total Debt | 123.88M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 4.76 |
| Book Value Per Share | 15.17 |
| 52-Week Change | -31.82 |
| 52-Week High | 21.33 |
| 52-Week Low | 13.37 |
| Moving Average 50 Days | 14.53 |
| Moving Average 200 Days | 16.88 |
| Average Volume | 3.19M |
| Shares Outstanding | 302.3M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.85 |
| Trailing Annual Dividend Yield | 5.89 |
| Payout Ratio | 1.09 |
| Last Split Factor | 6:5 |
| Last Split Date | April 28, 2026 |